|
|
||||||||
1, and PKC-
mediate high-glucose-induced vascular endothelial growth factor expression in mesangial cells1University Health Network, 3Mt. Sinai Hospital and 2Department of Medicine, University of Toronto, Toronto, Ontario, Canada
Submitted 10 April 2007 ; accepted in final form 4 August 2007
Vascular endothelial growth factor (VEGF) is implicated in the development of proteinuria in diabetic nephropathy. High ambient glucose present in diabetes stimulates VEGF expression in several cell types, but the molecular mechanisms are incompletely understood. Here primary cultured rat mesangial cells served as a model to investigate the signal transduction pathways involved in high-glucose-induced VEGF expression. Exposure to high glucose (25 mM) significantly increased VEGF mRNA evaluated by real-time PCR by 3 h, VEGF cellular protein content assessed by immunoblotting or immunofluorescence within 24 h, and VEGF secretion by 24 h. High-glucose-induced VEGF expression was blocked by an antioxidant, Tempol, and antisense oligonucleotides directed against p22phox, a NADPH oxidase subunit. Inhibition of protein kinase C (PKC)-
1 with the specific pharmacological inhibitor LY-333531 or inhibition of PKC-
with a cell permeable specific pseudosubstrate peptide also prevented enhanced VEGF expression in high glucose. Enhanced VEGF secretion in high glucose was prevented by Tempol, PKC-
1, or PKC-
inhibition. In normal glucose (5.6 mM), overexpression of p22phox or constitutively active PKC-
enhanced VEGF expression. Hypoxia inducible factor-1
protein was significantly increased in high glucose only by 24 h, suggesting a possible contribution to high-glucose-stimulated VEGF expression at later time points. Thus reactive oxygen species generated by NADPH oxidase, and both PKC-
1 and -
, play important roles in high-glucose-stimulated VEGF expression and secretion by mesangial cells.
NADPH oxidase; vascular endothelial growth factor; p22phox; protein kinase C-
1; protein kinase C-
This article has been cited by other articles:
![]() |
D. J. Kelly, A. J. Edgley, Y. Zhang, K. Thai, S. M. Tan, A. J. Cox, A. Advani, K. A. Connelly, C. I. Whiteside, and R. E. Gilbert Protein kinase C-{beta} inhibition attenuates the progression of nephropathy in non-diabetic kidney disease Nephrol. Dial. Transplant., June 1, 2009; 24(6): 1782 - 1790. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. N. Lavrentyev and K. U. Malik High glucose-induced Nox1-derived superoxides downregulate PKC-{beta}II, which subsequently decreases ACE2 expression and ANG(1-7) formation in rat VSMCs Am J Physiol Heart Circ Physiol, January 1, 2009; 296(1): H106 - H118. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Xia, H. Wang, S. Munk, J. Kwan, H. J. Goldberg, I. G. Fantus, and C. I. Whiteside High glucose activates PKC-{zeta} and NADPH oxidase through autocrine TGF-{beta}1 signaling in mesangial cells Am J Physiol Renal Physiol, December 1, 2008; 295(6): F1705 - F1714. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |